Brandywine Global Investment Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-265,898
Closed -$14.6M 1047
2016
Q1
$14.6M Sell
265,898
-2,862
-1% -$156K 0.1% 185
2015
Q4
$16.6M Buy
268,760
+2,131
+0.8% +$134K 0.11% 165
2015
Q3
$16.8M Buy
266,629
+43,969
+20% +$3.14M 0.11% 166
2015
Q2
$16.3M Buy
222,660
+7,369
+3% +$532K 0.1% 178
2015
Q1
$14.1M Buy
215,291
+4,790
+2% +$319K 0.09% 200
2014
Q4
$13.7M Buy
210,501
+17,980
+9% +$1.16M 0.09% 189
2014
Q3
$11.6M Buy
192,521
+33,410
+21% +$2.18M 0.09% 212
2014
Q2
$11M Buy
159,111
+21,400
+16% +$1.39M 0.09% 205
2014
Q1
$9.01M Buy
137,711
+11
+0% +$716 0.08% 232
2013
Q4
$8.53M Buy
137,700
+1,634
+1% +$94.6K 0.08% 234
2013
Q3
$7.3M Buy
136,066
+10,836
+9% +$558K 0.07% 257
2013
Q2
$5.71M Buy
+125,230
New +$5.43M 0.06% 300

Other funds holding STJ

Brandywine Global Investment Management's STJ Position: Q2 2016 in Review

Brandywine Global Investment Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 265,898 shares — an estimated $14.6M sold.

Brandywine Global Investment Management first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $16.8M in Q3 2015. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Brandywine Global Investment Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Brandywine Global Investment Management sold 265,898 St Jude Medical shares in Q2 2016, an estimated $14.6M.
  • Brandywine Global Investment Management first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
  • Brandywine Global Investment Management's St Jude Medical position peaked at $16.8M in Q3 2015.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Brandywine Global Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.